# Extreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF)

> **NCT04589572** · NA · SUSPENDED · sponsor: **Hasselt University** · enrollment: 40 (estimated)

## Conditions studied

- Muscle Damage
- Atrophy
- Degenerative Diseases, Spinal Cord

## Interventions

- **PROCEDURE:** XLIF
- **PROCEDURE:** PLIF

## Key facts

- **NCT ID:** NCT04589572
- **Lead sponsor:** Hasselt University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2020-01-01
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-11-01
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Because of COVID-19
- **Last updated:** 2022-05-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04589572

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04589572, "Extreme Lateral Interbody FusionFUSION (XLIF) Versus Posterior Lumbar Interbody Fusion (PLIF)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04589572. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*